Edward K. L. Chan

Dr. Edward K. L. Chan

Department of Oral Biology, University of Florida, Gainesville, FL 32610, USA
orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Cell
Verified
Journal Article
Closed access
CCChing-Yi Chen
Ching-Yi Chen
RGRoberto Gherzi
Roberto Gherzi
SOShao-En Ong
Shao-En Ong
ECEdward K. L. Chan
Edward K. L. Chan
RRReinout Raijmakers
Reinout Raijmakers
MKMichael Karin
Michael Karin

29 August 2008 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
KPKaleb M Pauley
Kaleb M Pauley
MSMinoru Satoh
Minoru Satoh
ACAnnie L Chan
Annie L Chan
MBMichael R Bubb
Michael R Bubb
WRWestley H Reeves
Westley H Reeves
ECEdward K. L. Chan
Edward K. L. Chan
Introduction: MicroRNAs are small noncoding RNA molecules that negatively regulate gene expression via degradation or translational repression of their targeted mRNAs. It is known that aberrant microRNA expression can play important roles in cancer, but the role of microRNAs in autoimmune diseases is only beginning to emerge. In this study, the expression of selected microRNAs is examined in rheumatoid arthritis. Methods: Total RNA was isolated from peripheral blood mononuclear cells obtained from patients with rheumatoid arthritis, and healthy and disease control individuals, and the expression of miR-146a, miR-155, miR-132, miR-16, and microRNA let-7a was analyzed using quantitative real-time PCR. Results: Rheumatoid arthritis peripheral blood mononuclear cells exhibited between 1.8-fold and 2.6-fold increases in miR-146a, miR-155, miR-132, and miR-16 expression, whereas let-7a expression was not significantly different compared with healthy control individuals. In addition, two targets of miR-146a, namely tumor necrosis factor receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK-1), were similarly expressed between rheumatoid arthritis patients and control individuals, despite increased expression of miR-146a in patients with rheumatoid arthritis. Repression of TRAF6 and/or IRAK-1 in THP-1 cells resulted in up to an 86% reduction in tumor necrosis factor-α production, implicating that normal miR-146a function is critical for the regulation of tumor necrosis factor-α production. Conclusions: Recent studies have shown that synovial tissue and synovial fibroblasts from patients with rheumatoid arthritis exhibit increased expression of certain microRNAs. Our data thus demonstrate that microRNA expression in rheumatoid arthritis peripheral blood mononuclear cells mimics that of synovial tissue/fibroblasts. The increased microRNA expression in rheumatoid arthritis patients is potentially useful as a marker for disease diagnosis, progression, or treatment efficacy, but this will require confirmation using a large and well defined cohort. Our data also suggest a possible mechanism contributing to rheumatoid arthritis pathogenesis, whereby miR-146a expression is increased but unable to properly function, leading to prolonged tumor necrosis factor-α production in patients with rheumatoid arthritis.

1 July 2007 in Cell
Verified
Journal Article
Closed access
MJMelissa R. Junttila
Melissa R. Junttila
PPPietri Puustinen
Pietri Puustinen
MNMinna Niemelä
Minna Niemelä
RARaija Ahola
Raija Ahola
HAHugh Arnold
Hugh Arnold
Jukka WestermarckJukka Westermarck
Jukka Westermarck

1 January 2014 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
NANancy Agmon-Levin
Nancy Agmon-Levin
JDJan Damoiseaux
Jan Damoiseaux
CKCees Kallenberg
Cees Kallenberg
USUlrich Sack
Ulrich Sack
TWTorsten Witte
Torsten Witte
YSYehuda Shoenfeld
Yehuda Shoenfeld
Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1–13), anti-double stranded DNA antibodies (14–18), specific antibodies (19–23) and validation of methods (24–25) were created. Significant differences between experts were observed regarding recommendations 24–25 (p<0.03). Here, we formulated recommendations for the assessment and interpretation of ANA and associated antibodies. Notably, the roles of IIFA as a reference method, and the importance of defining nuclear and cytoplasmic staining, were emphasised, while the need to incorporate alternative automated methods was acknowledged. Various approaches to overcome discrepancies between methods were suggested of which an improved bench-to-bedside communication is of the utmost importance. These recommendations are based on current knowledge and can enable harmonisation of local algorithms for testing and evaluation of ANA and related autoantibodies. Last but not least, new more appropriate terminologies have been suggested.

1 May 2009 in Journal of Autoimmunity
Verified
Journal Article
Closed access
KPKaleb M. Pauley
Kaleb M. Pauley
SCSeunghee Cha
Seunghee Cha
ECEdward K. L. Chan
Edward K. L. Chan

13 November 2005 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
AJAndrew Jakymiw
Andrew Jakymiw
SLShangli Lian
Shangli Lian
TETheophany Eystathioy
Theophany Eystathioy
SLSongqing Li
Songqing Li
MSMinoru Satoh
Minoru Satoh
ECEdward K. L. Chan
Edward K. L. Chan